ConductScience.org, home

Paper39903363

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.

Chen W and 2 others. Curr HIV/AIDS Rep, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places. Papers, record 39903363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39903363

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.
PubMed
Journal
Curr HIV/AIDS Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.65, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen WWenxuan
2Berkhout BBen
3Pasternak AOAlexander O

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV-1Major topic
HIV InfectionsMajor topic
Virus LatencyMajor topic
CD4-Positive T-LymphocytesMajor topic
Disease ReservoirsMajor topic
Humans
Phenotype
Proviruses

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
09120011910035Dutch Medical Research Council (ZonMw)PubMed
1110680-77-RPRLamfAR, The Foundation for AIDS ResearchPubMed
KICH2.V4P.AF23.001Partnership NWO-Dutch AIDS Fonds 'HIV cure for everyone'PubMed

Source PubMed

Download CSV of grants

References156

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124152939The end of AIDS: HIV infection as a chronic disease.Lancet2013https://conductscience.org/library/papers/24152939PubMed
29144289Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature1997https://conductscience.org/library/papers/9144289PubMed
39360927Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science1997https://conductscience.org/library/papers/9360927PubMed
412754504Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.Nat Med2003https://conductscience.org/library/papers/12754504PubMed
525877550Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.J Infect Dis2015https://conductscience.org/library/papers/25877550PubMed
619543283HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.Nat Med2009https://conductscience.org/library/papers/19543283PubMed
724968937HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.Science2014https://conductscience.org/library/papers/24968937PubMed
825011556HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.Science2014https://conductscience.org/library/papers/25011556PubMed
916775332Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.J Virol2006https://conductscience.org/library/papers/16775332PubMed
1026858442Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26858442PubMed
1130446650A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.Nat Commun2018https://conductscience.org/library/papers/30446650PubMed
1226814962Persistent HIV-1 replication maintains the tissue reservoir during therapy.Nature2016https://conductscience.org/library/papers/26814962PubMed
1334387543Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy.Elife2021https://conductscience.org/library/papers/34387543PubMed
1427078619Persistent HIV-1 replication during antiretroviral therapy.Curr Opin HIV AIDS2016https://conductscience.org/library/papers/27078619PubMed
1524243014Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.Cell2013https://conductscience.org/library/papers/24243014PubMed
1627500724Defective proviruses rapidly accumulate during acute HIV-1 infection.Nat Med2016https://conductscience.org/library/papers/27500724PubMed
1729045846Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants.Cell Rep2017https://conductscience.org/library/papers/29045846PubMed
1830760706Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.Nat Commun2019https://conductscience.org/library/papers/30760706PubMed
1936596305Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host Microbe2023https://conductscience.org/library/papers/36596305PubMed
2035026153Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses.Cell2022https://conductscience.org/library/papers/35026153PubMed

See all 156 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42515607Ebola Virus Persistence Beyond Acute Infection: Could HIV-Associated Immune Dysfunction Influence Survivor Biology?Viruses2026https://conductscience.org/library/papers/42515607PubMed
42139147Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control.Curr Opin HIV AIDS2026https://conductscience.org/library/papers/42139147PubMed
41772600TARDBP as a regulator of HIV-1 assembly and infection: a review of targeting the viral capsid precursor Pr55Gag and limiting viral core entry.Cell Commun Signal2026https://conductscience.org/library/papers/41772600PubMed
41754496Potential Impact of SARS-CoV-2 Spike Protein on HIV-1 Reservoir in People Living with HIV.Viruses2026https://conductscience.org/library/papers/41754496PubMed
41729081Single-cell capture of on-ART SIV transcription reveals TGF-β-mediated metabolic control of viral latency.JCI Insight2026https://conductscience.org/library/papers/41729081PubMed
40943350Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.Int J Mol Sci2025https://conductscience.org/library/papers/40943350PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
FCGR2A2212PubTator's text mininghttps://conductscience.org/library/genes/2212NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39903363

GET https://conductscience.org/api/papers/v1/39903363/references?page=2